www.sciencedaily.com
Researchers have identified a molecular interaction that accelerates Parkinson’s by damaging the brain’s energy systems. To counter this, they designed a treatment that intercepts this harmful process, protecting brain cells and restoring function. In lab and animal models, the intervention improved movement and cognitive performance while reducing inflammation. Unlike current treatments that address symptoms, this approach targets the root cause of the disease. These findings point toward a new generation of Parkinson’s therapies that may prevent or reverse neurodegeneration rather than merely managing symptoms.
Read More
